Sabre Insurance Group (LON:SBRE) Price Target Raised to GBX 278 at Barclays

Share on StockTwits

Sabre Insurance Group (LON:SBRE) had its target price raised by Barclays from GBX 277 ($3.62) to GBX 278 ($3.63) in a research report released on Wednesday morning, Stock Target Advisor reports. The brokerage currently has an equal weight rating on the stock.

A number of other equities research analysts have also recently issued reports on SBRE. Peel Hunt reissued a buy rating and issued a GBX 300 ($3.92) target price on shares of Sabre Insurance Group in a research report on Thursday, October 10th. Peel Hunt reaffirmed an add rating on shares of Sabre Insurance Group in a research report on Tuesday, November 19th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Sabre Insurance Group has an average rating of Hold and an average price target of GBX 295.60 ($3.86).

SBRE stock traded down GBX 0.50 ($0.01) during trading hours on Wednesday, hitting GBX 296 ($3.87). 182,308 shares of the stock were exchanged, compared to its average volume of 249,083. The company has a current ratio of 1.25, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $740.00 million and a P/E ratio of 15.34. The company has a 50-day simple moving average of GBX 294.86 and a two-hundred day simple moving average of GBX 278.09. Sabre Insurance Group has a 12 month low of GBX 252 ($3.29) and a 12 month high of GBX 312 ($4.08).

Sabre Insurance Group Company Profile

Sabre Insurance Group plc, through its subsidiaries, engages in the writing of general insurance for motor vehicles in the United Kingdom. The company offers its products through a network of insurance brokers, as well as through its own direct brands, including the Go Girl, Insure 2 Drive, and Drive Smart.

Recommended Story: Guidelines for Successful Channel Trading

Analyst Recommendations for Sabre Insurance Group (LON:SBRE)

Receive News & Ratings for Sabre Insurance Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabre Insurance Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.